BioSpace News Archive

Schrödinger announced an expanded collaboration with AstraZeneca focused on refining a biologics modeling solution with the aim of speeding up the development of antibody and protein-based therapeutic candidates.

Bristol-Myers Squibb Company announced that due to the ongoing COVID-19 pandemic, it will reschedule its planned April 2, 2020 Investor Day for a later date.

BELLUS to own 100% of BLU-5937 and related P2X3 antagonists intellectual property with no future payments due -

Withdraws Previous 2020 Growth Outlook Implementing furlough of approximately 1/3 of its direct workforce and substantially all of its temporary workforce Furloughed employees will be immediately eligible for unemployment benefits and will maintain their existing healthcare coverage through Conformis Continuing to produce backlog orders and new orders; Interruptions in supply chain are not currently anticipated Continuing to progress new product development programs BILLERICA, Ma

Quebec City biopharmaceutical company moving towards testing stages of COVID-19 vaccine candidate

ndivior PLC (LON: INDV) today announced the publication of one-year outcomes from a 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and Socio-Economic Factors on Recovery).

Conference call and live webcast was previously scheduled for 8:30 AM (EDT)

Favorable SB206 Week 24 safety and scarring profiles Type C teleconference with FDA for SB206 remains scheduled on April 1, 2020 Novan intends to screen NVN1000 against a number of viruses, including SARS-CoV-2 MORRISVILLE, N.C., March 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced data from the prospectively planned safety evaluation through Week 24 as part of the Company’s Phase 3 B-SIMPLE program with SB206 for the treatment of mo

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Jet-Oxide ® 15% post-harvest sanitizer and industrial disinfectant product is now allowed by the U.S. EPA for use against human coronaviruses to sanitize industrial food and agricultural hard surfaces. The allowed use was based on a study conducted by the EPA wit

ALR Technologies, Inc. announces their ALRT Diabetes Solution platform provides the tools physicians need to offer telehealth, telemedicine, and remote patient monitoring services to their patients with diabetes. The expanded reimbursements for telehealth services, recently announced by the Centers for Medicare and Medicaid Services (CMS) due to the coronavirus outbreak, is especially h